Medication guide
Brimonidine Tartrate (0.025%)
- Generic name
- Brimonidine Tartrate (0.025%)
- Common brand names
- Lumify Redness Reliever
- Medication class
- Ophthalmic alpha-agonist vasoconstrictor
Overview
Its medication class is Ophthalmic alpha-agonist vasoconstrictor. Common uses include Temporary eye redness relief. Product forms and labels can differ, so follow the specific package instructions and ask a pharmacist or qualified healthcare professional about individual questions.
How to Take it
- Route
- Ophthalmic drops/lubricants.
- Time of day
- Use at symptom onset and before prolonged screen/irritating exposure if needed.
- With food/water
- No food relationship; avoid contact with water before instillation.
- Preparation
- Hand wash, pull lower lid down, apply drop; do not touch tip to eye.
- Safe dose
- One to two drops per eye unless label says otherwise.
- Max dose
- Do not exceed label daily frequency/number of drops.
- Frequency
- Every few hours to 2 times/day depending product and symptoms.
- Other recommendations
- Remove contact lenses if instructed and wait if discomfort persists >5 minutes.
Common uses
- Temporary eye redness relief
Common side effects
- Eye burning/stinging
- blurred vision
- headache
- rebound redness
- and dryness
Important warnings
- Avoid prolonged regular use to reduce rebound redness. Do not combine with other vasoconstrictor drops. Seek care for persistent headache, pain, visual disturbances, or severe burning/redness.
General interactions information
Avoid combining with other decongesting eye drops
Sources / references
- Brimonidine Ophthalmic — MedlinePlus
U.S. National Library of Medicine
These references offer further reading. A source link does not establish that a clinician has reviewed every statement in this guide.
Editorial record
Recorded content review date:
A named medical reviewer and their credentials have not yet been documented for this guide.
Editorial standards and corrections